VivoSim Labs Inc (VIVS) concluded trading on Thursday at a closing price of $1.87, with 4.14 million shares of worth about $7.74 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -66.27% during that period and on April 24, 2025 the price saw a loss of about -8.33%. Currently the company’s common shares owned by public are about 1.70M shares, out of which, 1.67M shares are available for trading.
Stock saw a price change of 12.65% in past 5 days and over the past one month there was a price change of -34.15%. Year-to-date (YTD), VIVS shares are showing a performance of -66.12% which decreased to -84.87% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.56 but also hit the highest price of $21.96 during that period. The average intraday trading volume for VivoSim Labs Inc shares is 752.45K. The stock is currently trading -6.37% below its 20-day simple moving average (SMA20), while that difference is down -54.28% for SMA50 and it goes to -64.41% lower than SMA200.
VivoSim Labs Inc (NASDAQ: VIVS) currently have 1.70M outstanding shares and institutions hold larger chunk of about 12.21% of that.
The stock has a current market capitalization of $3.18M and its 3Y-monthly beta is at 1.19. It has posted earnings per share of -$10.35 in the same period. It has Quick Ratio of 0.72 while making debt-to-equity ratio of 3.67. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for VIVS, volatility over the week remained 18.34% while standing at 14.08% over the month.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by H.C. Wainwright on December 13, 2018 offering a Buy rating for the stock and assigned a target price of $2.50 to it. Stock get an Overweight rating from Piper Jaffray on June 29, 2015.
